2009
DOI: 10.1007/s10616-009-9244-6
|View full text |Cite
|
Sign up to set email alerts
|

Protective effects of HFE7A, mouse anti-human/mouse Fas monoclonal antibody against acute and lethal hepatic injury induced by Jo2

Abstract: HFE7A is a mouse anti-human/mouse Fas monoclonal antibody which, protects mice from fulminant hepatitis induced by Jo2. Herein, we report on the mechanism of the protective effect of HFE7A against Jo2-induced acute and lethal hepatic injury.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2012
2012
2014
2014

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 31 publications
0
4
0
Order By: Relevance
“…TNF‐receptor and Fas ligation are well‐characterized processes leading to massive apoptosis in various cellular models . The Fas‐mediated secretion of TNF‐α aggravates apoptosis .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…TNF‐receptor and Fas ligation are well‐characterized processes leading to massive apoptosis in various cellular models . The Fas‐mediated secretion of TNF‐α aggravates apoptosis .…”
Section: Discussionmentioning
confidence: 99%
“…TNF-receptor and Fas ligation are well-characterized processes leading to massive apoptosis in various cellular models. 21,43 The Fas-mediated secretion of TNF-a aggravates apoptosis. 2 Second, Fas activation might increase hepatic chemokines that recruit TNF-asecreting neutrophils to the liver.…”
Section: Discussionmentioning
confidence: 99%
“…These include vitamins, fatty acids and antibody (Edenharder et al 1999;Rao et al 2001;Yoshida et al 2010;Turkez et al 2012b). Concomitant treatment with the anti-oxidants provided protection against oxidative damage by mutagens in experimental animals (Abubakar et al 2003;Esparza et al 2003;Geyikoglu et al 2005;.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, extensive efforts were made to investigate therapeutic substances capable of reducing the genotoxicity of various natural and man-made mutagens in human life Turkez and Geyikoglu 2010b). Also, these include antibody, fatty acids, minerals and vitamins (Edenharder et al 1999;Rao et al 2001;Yoshida et al 2010;Turkez et al 2012a, b, c, d). Concomitant treatment with antioxidants provided protection against oxidative damage by mutagens in experimental animals (Abubakar et al 2003;Esparza et al 2003;Geyikoglu et al 2005;Turkez and Geyikoglu 2010a).…”
Section: Introductionmentioning
confidence: 99%